Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Long-Term Efficacy And Safety Of Ropeginterferon Alfa-2b In Patients With Polycythemia Vera - Final Phase I/Ii Peginvera Study Results

Heinz Gisslinger,Veronika Buxhofer-Ausch,Josef Thaler,Ernst Forjan,Ella Willenbacher,Dominik Wolf,Robert Kralovics,Bettina Gisslinger,Margarete Stampfl-Mattersberger,Alexander Egle,Thomas Melchardt,Sonja Burgstaller,Martin Schalling,Maria-Theresa Krauth,Richard Greil,Pavla Kadlecova,Michael Zoerer,Victoria Empson,Barbara Grohmann-Izay,Christoph Klade

BLOOD（2018）

Cited 14|Views55
No score
Abstract
Background: Ropeginterferon alfa-2b (Ropeg) is a novel long-acting monopegylated IFN-alpha-2b. Due to reduced dosing frequencies, better tolerability and improved compliance, Ropeg may be a favorable treatment option for long-term therapy in patients with polycythemia vera (PV).
More
Translated text
Key words
polycythemia vera,long-term
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined